Original Medicare now requires prior authorization for some procedures in six states under a new federal pilot

Hospital clipboard and doctor with old man for consulting medical service and diagnosis Healthcare clinic and woman with senior patient with paperwork for medicare insurance and prescription

Medicare beneficiaries in six states now need their doctors to get advance approval before certain procedures, a requirement that Original Medicare has largely avoided for decades. The Centers for Medicare and Medicaid Services launched the Wasteful and Inappropriate Service Reduction Model, known as WISeR, on January 1, 2026, introducing an AI-assisted prior authorization process in Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. The pilot will run for six years, and providers and Medicare Administrative Contractors began accepting prior authorization requests on January 5, 2026, for dates of service on or after that date.

How the WISeR Pilot Changes the Prior Authorization Process

Prior authorization has long been a fixture of Medicare Advantage plans run by private insurers. Original Medicare, the federal fee-for-service program, has historically operated without that gatekeeping step for most services. The WISeR Model breaks that pattern by requiring providers in the six pilot states to obtain approval before delivering select procedures. CMS describes the effort as testing an improved and expedited prior authorization process using enhanced technologies including artificial intelligence.

The agency has stated that coverage and payment criteria do not change under the model. That distinction matters. Medicare Advantage plans have drawn criticism for layering utilization management rules on top of standard Medicare coverage, sometimes denying care that Original Medicare would otherwise pay for. WISeR, by contrast, keeps the same coverage standards and adds a screening step designed to catch waste and inappropriate billing before payment goes out. If the model works as designed, it could produce fewer administrative denials than the private-plan approach, precisely because it applies existing Medicare rules rather than insurer-specific overlays. Whether that outcome materializes will depend on how the AI tools perform in practice and how quickly providers adapt to the new workflow.

CMS also emphasizes that the model is intended to be faster and more predictable than traditional paper-based reviews. The agency’s public FAQ describes an electronic submission process and automated assistance to help reviewers apply Medicare coverage rules consistently. In theory, that could shorten turnaround times and reduce back-and-forth requests for additional documentation. Still, the same technology that speeds approvals could accelerate denials if algorithms flag large volumes of claims as potentially inappropriate.

Federal Records Behind the Six-State Rollout

CMS formalized the pilot through Change Request 14205, which directed Medicare Administrative Contractors to implement the new prior authorization and medical review processes and established a quarterly update cycle for model attachments. The operational instructions to contractors are detailed in a transmittal document that spells out implementation timelines, coding requirements, and reporting expectations. The Government Accountability Office separately reviewed the WISeR notice and confirmed the six-year testing period beginning January 1, 2026, providing independent federal corroboration beyond CMS’s own announcements.

The choice of pilot states spans different regions and health care markets. Arizona, Texas, and Oklahoma represent large Sun Belt populations with significant Medicare enrollment. New Jersey and Ohio add density in the Northeast and Midwest. Washington rounds out the group on the West Coast. CMS has not published baseline data or projected impact metrics on denial rates or beneficiary access in these states, and the agency’s public documents do not list the specific procedures subject to prior authorization under WISeR. That gap leaves providers and patients without a clear public benchmark against which to measure the pilot’s early performance.

Quarterly updates to the WISeR attachments may eventually clarify which services are included, how review criteria are applied, and whether any adjustments are made in response to early experience. For now, however, the model’s contours are defined more by process than by a transparent list of targeted procedures. That makes it difficult for outside observers to evaluate whether the program is tightly focused on clearly wasteful care or casts a broader net that could inadvertently delay medically necessary treatment.

Unanswered Questions for Beneficiaries and Providers

Several significant unknowns hang over the first performance year. CMS has not released the full catalog of procedures that trigger the new prior authorization requirement, making it difficult for beneficiaries to know in advance whether a planned service will face a delay. The agency’s published guidance also contains no direct statements from providers or Medicare Administrative Contractors about implementation readiness beyond the January 5 start date. Without public measures of staffing levels, training completion, or system testing, patients must largely trust that the infrastructure behind the new process will function as intended.

Beneficiaries may encounter new friction points even though formal coverage rules remain unchanged. A physician who is unsure whether a service falls under WISeR might postpone scheduling until the practice can confirm the requirement and submit a request. If AI-supported reviewers issue initial denials that are later overturned on appeal, patients could experience anxiety and potential treatment delays even when ultimate payment is approved. CMS has not yet detailed how it will monitor these patient-level effects or what thresholds would trigger mid-course corrections.

Providers, meanwhile, face operational and financial questions. Practices must integrate WISeR workflows into their billing systems, train staff to prepare documentation tailored to the new review process, and track responses from multiple contractors across the six states. Smaller clinics and solo practitioners may feel these administrative burdens most acutely, especially if they lack dedicated billing departments. While CMS positions WISeR as a streamlined alternative to traditional prior authorization, the real-world workload will depend on how many services are swept into the model and how often contractors request additional information.

Over the six-year test, CMS plans to evaluate whether the model reduces spending on services deemed wasteful or inappropriate without harming access to necessary care. To build trust, the agency will likely need to publish data on approval rates, processing times, appeals, and any observed disparities among patient groups or regions within the pilot states. Until that evidence emerges, WISeR represents a significant shift for Original Medicare beneficiaries in Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington-one that promises more oversight and technological efficiency, but also introduces new layers of uncertainty at the point of care.

Leave a Reply

Your email address will not be published. Required fields are marked *